Reuters logo
BRIEF-A2 Acquisition Corp announces proposed qualifying transaction with Medicenna Therapeutics
February 6, 2017 / 2:38 PM / 10 months ago

BRIEF-A2 Acquisition Corp announces proposed qualifying transaction with Medicenna Therapeutics

Feb 6 (Reuters) - A2 Acquisition Corp -

* Announces proposed qualifying transaction with Medicenna Therapeutics Inc

* Says anticipated that a total of 21.2 million A2 consolidated shares will be issued in exchange for all Medicenna shares

* Previously announced letter of intent with Medicenna Therapeutics dated Nov 7, 2016 is superseded by a definitive agreement dated Feb 5

* Definitive agreement dated Feb 5 is between unit of A2 and Medicenna Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below